Skip to main content

Articles

Page 11 of 16

  1. Urinary tract infections (UTI) are commonly encountered in the emergency department (ED). ED culture follow up is an important tool to provide the appropriate therapy after the identification of the causative ...

    Authors: Abdulaziz Saleh Almulhim, Ali Aldayyen, Kateryna Yenina, Adam Chiappini and Tahir Mehmood Khan
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:8
  2. Proton pump inhibitors (PPIs) are used worldwide for the treatment of gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD). Although considered to be widely safe, PPIs have been associated wit...

    Authors: Ejaz Cheema
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:6
  3. Pharmacy-based interventions are complex public health endeavors which include, but are not restricted to, the conventional medication supply role. In diabetes, such interventions may improve patients’ outcome...

    Authors: Suzete Costa, Maria Rute Horta, Rita Santos, Zilda Mendes, Isabel Jacinto, José Guerreiro, Maria Cary, Ana Miranda, Dennis K. Helling and Ana Paula Martins
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:5
  4. The availability of medicines in public health facilities in Tanzania is problematic. Medicines shortages are often caused by unavailability at Medical Stores Department, the national supplier for public healt...

    Authors: Karin Wiedenmayer, Romuald Mbwasi, William Mfuko, Ezekiel Mpuya, James Charles, Fiona Chilunda, Denis Mbepera and Ntuli Kapologwe
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:4
  5. Self-medication is a common practice globally and the resulting irrational drug use is raising concerns. Up-to-date there is no systematic study conducted on self medication practice among students or the gene...

    Authors: Zenawi Zeramariam Araia, Nahom Kiros Gebregziabher and Araia Berhane Mesfun
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:3
  6. The National Drug Authority (NDA) inspects and certifies private and public sector pharmacies in Uganda using an indicator-based inspection tool that measures adherence to good pharmacy practices (GPP). 67 mea...

    Authors: Brian Sekayombya, David Nahamya, Laura Garabedian, Morries Seru and Birna Trap
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:2
  7. To stimulate use of generic medicines a combination of supply and demand side mechanisms are employed in the Latvian reimbursement system. It is reported that patients have high out-of-pocket pharmaceutical sp...

    Authors: Ieva Salmane Kulikovska, Elita Poplavska, Marija Ceha and Signe Mezinska
    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:1
  8. In Ghana, there is extensive over-the-counter dispensing of antibiotics, resulting in high levels of inappropriate use, and an increase in antibiotic resistance. Regulations prevent Licenced Chemical Sellers (...

    Authors: Samuel Afari-Asiedu, John Kinsman, Ellen Boamah-Kaali, Martha Ali Abdulai, Margaret Gyapong, Osman Sankoh, Marlies Hulscher, Kwaku Poku Asante and Heiman Wertheim
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:30
  9. High medicines prices increasingly pose challenges for universal access to treatments of communicable and non-communicable diseases. New essential medicines are often patent-protected which sustains high price...

    Authors: Ellen F. M. ‘t Hoen, Tapiwanashe Kujinga and Pascale Boulet
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:31
  10. In the United States (U.S.), large price increases for selected generic drugs have elicited public outrage. Recent legislative proposals aim to increase price transparency and identify outlier drug “price spik...

    Authors: Rena M. Conti, Kevin H. Nguyen and Meredith B. Rosenthal
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:29
  11. Pharmaceuticals are produced and consumed in increasing volume every year. Unfortunately, not all medications that go in to the hand of the consumers get consumed; large quantities remain unused or expire. The...

    Authors: Yohanes Ayele and Mulu Mamu
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:27
  12. Canadians have long been proud of their universal health insurance system, which publicly funds the cost of physician visits and hospitalizations at the point of care. Prescription drugs however, have been sub...

    Authors: Jaden Brandt, Brenna Shearer and Steven G. Morgan
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:28
  13. Cancer has become the third cause of death in Mexico. Treatment for cancer is often complex and lengthy. New and better medicines enter the market at high prices, which may limit access. Like most Latin Americ...

    Authors: Daniela Moye-Holz, Rene Soria Saucedo, Jitse P van Dijk, Sijmen A Reijneveld and Hans V Hogerzeil
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:25
  14. Rational prescribing remains an important component of rational drug use. The World Health Organization (WHO) standardized and validated core prescribing indicators for evaluating prescribing pattern of drugs....

    Authors: Tigist Gashaw, Mekonnen Sisay, Getnet Mengistu and Firehiwot Amare
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:26
  15. A strong pharmaceutical sector is a precondition for effective and efficient health care and financing systems, and thus for achieving the best possible health of a population. Supported by visionary, long-ter...

    Authors: Martin Oteba, Anita Katharina Wagner, Morries Seru, Martha Embrey and Birna Trap
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:23
  16. The United States-Peru Free Trade Agreement required changes in the Peruvian pharmaceutical legislation that resulted in the National Drug Policy (NDP) of 2009. This study evaluated the registration of brand a...

    Authors: Lita Araujo and Michael Montagne
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:24
  17. The emergency response phase to HIV epidemic in Nigeria and other countries saw to the deployment of donors’ resources with little consideration for country ownership (CO) and sustainability. The progress that...

    Authors: Ademola Joshua Itiola and Kenneth Anene Agu
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:21
  18. Pharmacists are critical for attaining the goal of universal health coverage and equitable access to essential health services, particularly in relation to access to medicines and medicines expertise. We descr...

    Authors: Aniekan Ekpenyong, Arit Udoh, Eneyi Kpokiri and Ian Bates
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:20
  19. In Australia, community pharmacists are increasingly being integrated into the healthcare system. A range of services in pharmacies are government-funded aiming to prevent chronic diseases and improve the qual...

    Authors: Vera H. Buss, Alison Shield, Sam Kosari and Mark Naunton
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:22
  20. Obesity is now widely regarded as a main contributor to poor health. Involvement of community pharmacists can be a valuable tool in obesity management. However, there is still a lack of data in Malaysia on the...

    Authors: Rohit Kumar Verma, Thomas Paraidathathu, Nur Akmar Taha and Wei Wen Chong
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:17
  21. The cost and potential harms of medicines and other health technologies are issues of concern for governments and third party payers of health care. Various means have been demonstrated to promote appropriate ...

    Authors: Lynn Maria Weekes, Suzanne Blogg, Sharene Jackson and Kerren Hosking
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:19
  22. Medication safety is a major public health concern and there are well established pharmacovigilance programmes in developed countries. However, there is scarcity of literature on the issue in low and middle in...

    Authors: Rabia Hussain, Mohamed Azmi Hassali, Furqan Hashmi and Maryam Farooqui
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:16
  23. In late 2010, Uganda introduced a supervision, performance assessment, and recognition strategy (SPARS) to improve staff capacity in medicines management in government and private not-for-profit health facilit...

    Authors: Birna Trap, Richard Musoke, Anthony Kirunda, Martin Olowo Oteba, Martha Embrey and Dennis Ross-Degnan
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:15
  24. The regulatory requirements for approval of generic medicines and the format of compiling drug dossiers vary among regulatory authorities. The variation is particularly wide between High-income countries (HIC)...

    Authors: D. Thambavita, P. Galappatthy and R. L. Jayakody
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:14
  25. Appropriate labeling of marketed medicines is necessary to fulfill the regulatory provisions and ensure patient medication safety. This study aimed to assess the primary labeling of medicines manufactured and ...

    Authors: Ramesh Sharma Poudel, Shakti Shrestha, Santosh Thapa, Bhupendra Kumar Poudel and Muniraj Chhetri
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:13
  26. Few guidelines exist on safe prescription of postoperative analgesia to obese patients undergoing ambulatory surgery. This study examines the preferences of providers in the standard treatment of postoperative...

    Authors: Anthony H. Bui, David L. Feldman, Michael L. Brodman, Peter Shamamian, Ronald N. Kaleya, Meg A. Rosenblatt, Debra D’Angelo, Donna Somerville, Santosh Mudiraj, Patricia Kischak and I. Michael Leitman
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:9
  27. To build capacity in medicines management, the Uganda Ministry of Health introduced a nationwide supervision, performance assessment and recognition strategy (SPARS) in 2012. Medicines management supervisors (...

    Authors: Belinda Blick, Stella Nakabugo, Laura F. Garabedian, Morries Seru and Birna Trap
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:11
  28. Today, a combination of globalization of pharmaceutical production, lack of regulatory harmonization, and weakness of Medicines Regulatory Authorities, creates the “perfect conditions” for poor-quality medicin...

    Authors: Raffaella Ravinetto, Tim Roosen and Catherine Dujardin
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:12
  29. The biennial Commonwealth Heads of Government Meeting (CHOGM) this year is based around four key themes: prosperity, fairness, sustainability and security. This is an opportune time to consider the role of pha...

    Authors: Victoria Rutter, Amy Hai Yan Chan, Chloe Tuck, Lina Bader, Zaheer-Ud-Din Babar and Ian Bates
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:10
  30. Antibiotic innovation has dwindled to dangerously low levels in the past 30 years. Since resistance continues to evolve, this innovation deficit can have perilous consequences on patients. A number of new ince...

    Authors: Christine Årdal, Enrico Baraldi, Ursula Theuretzbacher, Kevin Outterson, Jens Plahte, Francesco Ciabuschi and John-Arne Røttingen
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:8
  31. In order to engage pharmacies in tuberculosis (TB) care, a survey was conducted in the Dera Ismail (DI) Khan City of the Khyber Pakhtoon Khwa province, Pakistan. The objectives were to; 1) characterize the ret...

    Authors: Tehmina Mustafa, Yasir Shahzad and Ayyaz Kiani
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:7
  32. Biosimilars could be a promising option to help decrease healthcare costs and expand access to treatment. There is no previous evidence of a global bibliometric analysis on biosimilars. Therefore, we aimed to ...

    Authors: Akram Hernández-Vásquez, Christoper A. Alarcon-Ruiz, Guido Bendezu-Quispe, Daniel Comandé and Diego Rosselli
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:6
  33. Australian Government subsidisation of ipilimumab for the treatment of patients with metastatic melanoma was conditional on the sponsor entering a ‘managed entry scheme’ to assess the 2-year overall survival r...

    Authors: Hansoo Kim, Samantha Comey, Karl Hausler and Greg Cook
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:4
  34. Almost half of the world’s total population reside in rural and remote areas and a large number of these people remain deprived of most basic facilities like healthcare and education. It is deemed impossible f...

    Authors: Tariq Kazim Shah, Tasneem Tariq, Roger Phillips, Steve Davison, Adam Hoare, Syed Shahzad Hasan and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:3
  35. Hospital pharmacists play a central role in medication safety activities. However, in Ethiopia, this role has been launched recently and little is known regarding the current status of this extended service. U...

    Authors: Alemayehu B. Mekonnen, Andrew J. McLachlan, Jo-anne E. Brien, Desalew Mekonnen and Zenahebezu Abay
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:2
  36. To analyse trends in the rates of consumption of benzodiazepine (BZD) anxiolytics, BZD hypnotics and non-BZD hypnotics and the association with contextual factors.

    Authors: Miguel Angel Fernández García, Antonio Olry de Labry Lima, Ingrid Ferrer Lopez and Clara Bermúdez-Tamayo
    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:1
  37. In most developing countries including Ghana, there is scant literature on the involvement of the community pharmacist in the care of patients with chronic conditions such as hypertension and blood pressure co...

    Authors: Afia Frimpomaa Asare Marfo and Frances Thelma Owusu-Daaku
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:39
  38. The National Return of Unwanted Medicines (NatRUM) program in Australia is one of the few nationally coordinated, free-to-consumer schemes to dispose of unwanted medicines globally. This scheme has been in ope...

    Authors: Amanda J. Wheeler, Jean Spinks, Emilie Bettington and Fiona Kelly
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:38
  39. Hypertension is the most prevalent cardiovascular disease in Zimbabwe. The prevalence of Hypertension in the country is above 30% regardless of the cut off used. Currently, majority of patients in Zimbabwe see...

    Authors: Victor Basopo and Paschal N. Mujasi
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:37
  40. Evaluating outcomes after tuberculosis (TB) treatment can help identify the primary reasons for treatment success or failure. However, Yemen has a treatment success rate that remains below the World Health Org...

    Authors: Ammar Ali Saleh Jaber, Amer Hayat Khan and Syed Azhar Syed Sulaiman
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:36
  41. Uganda was one of seven countries in which the United Nations Commission on Life Saving Commodities (UNCoLSC) initiative was implemented starting from 2013. A nationwide survey was conducted in 2015 to determi...

    Authors: Denis Kibira, Freddy Eric Kitutu, Gemma Buckland Merrett and Aukje K. Mantel-Teeuwisse
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:35
  42. Community pharmacists are very accessible to most patients yet; they have been underutilized in the aspect of providing HIV care and services. The World Health Organisation recently recommended expanding commu...

    Authors: Nnenna Ajagu, Maureen Ugonwa Anetoh and Sunday Odunke Nduka
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:34
  43. Supportive supervision has been found to be more effective than corrective fault-oriented inspections. Uganda’s Ministry of Health in 2012 implemented a comprehensive strategy (SPARS) to build medicines manage...

    Authors: Rachael Henry, Lynda Nantongo, Anita Katharina Wagner, Martha Embrey and Birna Trap
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:33
  44. The UK Pharmaceutical Industry is arguably one of the most important industries to consider in the negotiations following the Brexit vote. Providing tens of thousands of jobs and billions in tax revenue and re...

    Authors: Fawz Kazzazi, Cleo Pollard, Paul Tern, Alejandro Ayuso-Garcia, Jack Gillespie and Inesa Thomsen
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:32
  45. High drug spending is a concern for policy makers due to limits on access for patients. Numerous policies have been proposed to address high drug spending. The existence of multifarious proposals makes it diff...

    Authors: Jeromie Ballreich, G. Caleb Alexander, Mariana Socal, Taruja Karmarkar and Gerard Anderson
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:31
  46. Despite making great progress in reducing under five mortality in the last three decades. Uganda still ranks high among countries with the highest under five mortality rates. More than a third (36%) of these d...

    Authors: Lorraine Nabbanja Kabunga and Paschal Mujasi
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:30
  47. Opioids are widely prescribed for chronic non cancer pain (CNCP). Controlled substance agreements (CSAs) are intended to increase adherence and mitigate risk with opioid prescribing. We evaluated the demograp...

    Authors: Lindsey M. Philpot, Priya Ramar, Muhamad Y. Elrashidi, Raphael Mwangi, Frederick North and Jon O. Ebbert
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:29
  48. Different methods in pharmacoepidemiology can be used to study hypnotic use in children. But neither questionnaire-based data nor prescription records can be considered a “gold standard”. This study aimed to i...

    Authors: Ingvild Holdø, Jørgen G. Bramness, Marte Handal, Leila Torgersen, Ted Reichborn-Kjennerud, Eivind Ystrøm, Hedvig Nordeng and Svetlana Skurtveit
    Citation: Journal of Pharmaceutical Policy and Practice 2017 10:28

Annual Journal Metrics

  • 2022 Citation Impact
    4.2 - 2-year Impact Factor
    1.266 - SNIP (Source Normalized Impact per Paper)
    0.574 - SJR (SCImago Journal Rank)

    2023 Speed
    28 days submission to first editorial decision for all manuscripts (Median)
    104 days submission to accept (Median)

    2023 Usage
    852,978 downloads
    963 Altmetric mentions